Scopus BioPharma
New York
About Scopus BioPharma
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company's lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2021)
- Ticker: nasdaq:SCPS
- Website: scopusbiopharma.com
Industries & Categories
Biopharma, Biotechnology, Cannabis, Medical
Social Profiles
Canonical: https://fsome.com/organization/scopus-biopharma-2231569 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.